You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方盛製藥(603998.SH):原料藥I車間依折麥布生產線通過GMP符合性檢查
格隆匯 11-15 18:36

格隆匯11月15日丨方盛製藥(603998.SH)公佈,近日,公司收到湖南省藥品監督管理局簽發的《藥品GMP符合性檢查結果》,公司位於湖南望城經濟開發區銅官鎮的原料藥I車間依折麥布生產線通過現場檢查,即GMP符合性檢查。

本次通過GMP符合性檢查為公司新建原料藥I車間依折麥布生產線的相關檢查,本次檢查相關直接投入約為人民幣1360.41萬元。

本次通過GMP審查的是公司原料藥I車間依折麥布生產線,國內方面,經查詢,已批准在上市制劑使用的依折麥布原料/輔料/包材有5家企業,但均未披露相關生產、銷售數據。終端產品依折麥布片適用於治療原發性高膽固醇血癥、純合子家族性高膽固醇血癥、純合子谷甾醇血癥(或植物甾醇血癥)。國內目前有原研廠家默沙東公司銷售的依折麥布2019年在中國城市公立醫院、縣級公立醫院、城市社區中心以及鄉鎮衞生院終端的銷售額超5億元,同比增長約50.76%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account